 John DeSisto
Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 8 | 2025 | 354 | 3.000 |
Why?
| | Brain Neoplasms | 7 | 2025 | 1171 | 1.520 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2025 | 28 | 0.930 |
Why?
| | Radiation | 1 | 2021 | 24 | 0.740 |
Why?
| | Neoplastic Stem Cells | 1 | 2025 | 380 | 0.700 |
Why?
| | Meninges | 1 | 2020 | 43 | 0.660 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 2019 | 17 | 0.650 |
Why?
| | Karyopherins | 1 | 2019 | 19 | 0.650 |
Why?
| | NF-kappa B | 2 | 2019 | 653 | 0.600 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 217 | 0.570 |
Why?
| | Transcriptome | 2 | 2021 | 887 | 0.560 |
Why?
| | Fibroblasts | 1 | 2020 | 948 | 0.480 |
Why?
| | Microbubbles | 2 | 2024 | 48 | 0.450 |
Why?
| | Blood-Brain Barrier | 2 | 2024 | 132 | 0.420 |
Why?
| | Rhabdoid Tumor | 2 | 2025 | 98 | 0.410 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2025 | 1356 | 0.390 |
Why?
| | DNA Copy Number Variations | 2 | 2023 | 170 | 0.370 |
Why?
| | Hydrazines | 2 | 2025 | 34 | 0.360 |
Why?
| | Cerebellar Neoplasms | 2 | 2023 | 156 | 0.330 |
Why?
| | Triazoles | 2 | 2025 | 152 | 0.330 |
Why?
| | Neoplasm Grading | 2 | 2021 | 285 | 0.320 |
Why?
| | Medulloblastoma | 2 | 2023 | 198 | 0.320 |
Why?
| | Brain | 2 | 2024 | 2679 | 0.310 |
Why?
| | Ependymoma | 2 | 2023 | 177 | 0.300 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1706 | 0.260 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 3215 | 0.260 |
Why?
| | Disease Progression | 2 | 2024 | 2635 | 0.260 |
Why?
| | Sirtuin 2 | 1 | 2025 | 24 | 0.240 |
Why?
| | SMARCB1 Protein | 1 | 2025 | 29 | 0.240 |
Why?
| | Sonication | 1 | 2024 | 13 | 0.230 |
Why?
| | Child | 8 | 2025 | 20883 | 0.230 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 195 | 0.210 |
Why?
| | Mice | 7 | 2025 | 16937 | 0.210 |
Why?
| | Carcinogenesis | 1 | 2025 | 213 | 0.210 |
Why?
| | Central Nervous System Neoplasms | 1 | 2025 | 149 | 0.210 |
Why?
| | Astrocytoma | 1 | 2023 | 122 | 0.200 |
Why?
| | Antineoplastic Agents | 3 | 2020 | 2061 | 0.200 |
Why?
| | Microglia | 1 | 2024 | 235 | 0.200 |
Why?
| | Teratoma | 1 | 2023 | 105 | 0.200 |
Why?
| | raf Kinases | 1 | 2021 | 11 | 0.190 |
Why?
| | Gene Ontology | 1 | 2021 | 51 | 0.190 |
Why?
| | Epigenesis, Genetic | 2 | 2023 | 613 | 0.180 |
Why?
| | Recurrence | 1 | 2023 | 1007 | 0.170 |
Why?
| | Single-Cell Analysis | 2 | 2020 | 277 | 0.170 |
Why?
| | DNA Methylation | 2 | 2023 | 607 | 0.170 |
Why?
| | Genes, myc | 1 | 2020 | 50 | 0.170 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2021 | 201 | 0.170 |
Why?
| | Crystallins | 1 | 2020 | 59 | 0.160 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 312 | 0.160 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2020 | 432 | 0.160 |
Why?
| | Pyrimidinones | 1 | 2020 | 103 | 0.160 |
Why?
| | Histones | 1 | 2024 | 588 | 0.160 |
Why?
| | Cell Proliferation | 2 | 2025 | 2391 | 0.160 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2025 | 964 | 0.160 |
Why?
| | Animals | 8 | 2025 | 35361 | 0.160 |
Why?
| | Humans | 16 | 2025 | 129650 | 0.160 |
Why?
| | Deoxycytidine | 1 | 2020 | 165 | 0.150 |
Why?
| | Everolimus | 1 | 2017 | 88 | 0.140 |
Why?
| | Phenotype | 2 | 2024 | 3076 | 0.140 |
Why?
| | Transfection | 1 | 2019 | 911 | 0.140 |
Why?
| | Mice, Inbred C57BL | 3 | 2024 | 5440 | 0.140 |
Why?
| | Computer Simulation | 1 | 2021 | 943 | 0.140 |
Why?
| | Morpholines | 1 | 2017 | 122 | 0.140 |
Why?
| | Brain Stem Neoplasms | 1 | 2017 | 89 | 0.130 |
Why?
| | Macrophages | 1 | 2024 | 1480 | 0.130 |
Why?
| | Inflammation | 2 | 2024 | 2736 | 0.130 |
Why?
| | Pyrazoles | 1 | 2020 | 405 | 0.130 |
Why?
| | Glioblastoma | 1 | 2019 | 326 | 0.130 |
Why?
| | Immunophenotyping | 1 | 2017 | 311 | 0.130 |
Why?
| | Cell Cycle | 2 | 2017 | 592 | 0.130 |
Why?
| | Cell Cycle Proteins | 1 | 2020 | 586 | 0.130 |
Why?
| | Cell Tracking | 1 | 2015 | 14 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2017 | 431 | 0.120 |
Why?
| | Tumor Suppressor Proteins | 1 | 2017 | 317 | 0.120 |
Why?
| | Cohort Studies | 2 | 2023 | 5420 | 0.120 |
Why?
| | Genetic Variation | 1 | 2019 | 937 | 0.110 |
Why?
| | Mutation | 1 | 2024 | 3717 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1181 | 0.100 |
Why?
| | Nuclear Proteins | 1 | 2017 | 663 | 0.100 |
Why?
| | Neoplasms | 1 | 2025 | 2470 | 0.090 |
Why?
| | Young Adult | 2 | 2025 | 12426 | 0.080 |
Why?
| | Adolescent | 3 | 2025 | 20393 | 0.080 |
Why?
| | Female | 6 | 2025 | 68776 | 0.070 |
Why?
| | Ultrasonic Waves | 1 | 2024 | 5 | 0.060 |
Why?
| | Receptors, CCR1 | 1 | 2024 | 4 | 0.060 |
Why?
| | Maximum Tolerated Dose | 1 | 2025 | 193 | 0.060 |
Why?
| | Receptors, CCR5 | 1 | 2024 | 57 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2025 | 1902 | 0.060 |
Why?
| | Histology | 1 | 2023 | 4 | 0.050 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2023 | 18 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2024 | 143 | 0.050 |
Why?
| | Cell Survival | 2 | 2017 | 1086 | 0.050 |
Why?
| | Particle Size | 1 | 2024 | 355 | 0.050 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2023 | 71 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3408 | 0.050 |
Why?
| | Male | 6 | 2025 | 63681 | 0.050 |
Why?
| | Mitosis | 1 | 2023 | 180 | 0.050 |
Why?
| | Contrast Media | 1 | 2024 | 394 | 0.050 |
Why?
| | Cerebellum | 1 | 2023 | 219 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2024 | 336 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 429 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2023 | 478 | 0.040 |
Why?
| | Child, Preschool | 2 | 2025 | 10517 | 0.040 |
Why?
| | Infant | 2 | 2023 | 9024 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2017 | 62 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 119 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 207 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 827 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 487 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2019 | 638 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2017 | 366 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2017 | 345 | 0.030 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2015 | 113 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1651 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2015 | 95 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2020 | 2119 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4063 | 0.030 |
Why?
| | Pyrimidines | 1 | 2017 | 459 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 354 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 2015 | 317 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2012 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 1713 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1207 | 0.030 |
Why?
| | Prognosis | 1 | 2019 | 3794 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 10230 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 5762 | 0.020 |
Why?
|
|
DeSisto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|